"A Better Approach to Healthcare We believe women deserve a better patient experience than they are receiving in the traditional healthcare model. Our process is focused on intensely personal treatment plans, a focus on health as well as overall wellness, and follow-ups with patients to ensure continuing well-being."

During the past decade, Women's Health Practice conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's Health Practice" #1 sponsor was "Curatek Pharmaceuticals, LLC" with 3 trials, followed by "Becton, Dickinson and Company" with 2 trials sponsored, "Acerus Pharmaceuticals Corporation" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "FemmePharma Global Healthcare, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Health Practice" #1 collaborator was "Covance" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Women's Health Practice" are "Vaginal Infection" (4 trials), "Fibrocystic Disease of Breast" (2 trials), "Bacterial Vaginosis" (1 trials), "Cervical Neoplasms" (1 trials) and "Female Orgasmic Disorder" (1 trials). Many other conditions were trialed in "Women's Health Practice" in a lesser frequency.

Most popular intervention types in "Women's Health Practice" are "Drug" (14 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Metronidazole" (4 trials), "Colposcopy" (2 trials), "Terconazole" (2 trials) and "BD HPV Assay on Viper LT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Women's Health Practice" are 15 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Women's Health Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Women's Health Practice, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Women's Health Practice, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".